Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)
Clinical trial NCT06045507 · COMPLETED
Trial details
- NCT number
- NCT06045507
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2024-12-12
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.